Dostarlimab
RxNorm 2539967
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2539967 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: dostarlimab.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Dostarlimab
(Atom ID: 12627960)
PTPrescribable
Designated preferred name (PT):
Dostarlimab
(Atom ID: 12664989)
FNPrescribable
Full form of descriptor (FN):
Dostarlimab (substance)
(Atom ID: 12664990)
PTPrescribable
Designated preferred name (PT):
Dostarlimab-containing product
(Atom ID: 12664993)
FNPrescribable
Full form of descriptor (FN):
Product containing dostarlimab (medicinal product)
(Atom ID: 12665528)
Patient Education
Dostarlimab-gxly Injection
Dostarlimab-gxly injection is used to treat a certain type of endometrial cancer (cancer that begins in the lining of the uterus) in adults that has progressed or has returned after treatment with other chemotherapy medication(s). Dostarlimab-gxly injection is in a class of medications called monoclonal antibodies. It works by blocking the action of a certain protein in cancer cells. This helps the person's immune system to fight against the cancer cells, and helps to slow tumor growth.
[Learn More]
* Please review the disclaimer below.